Company / PP&E (Net)
Solventum PP&E (Net) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$1.3B
FY2025
5-year range
$1.3B / $1.6B
FY2023-FY2025
Trend
-18.2%
vs FY2024
Sector context
#34 of 132
Health Care
What the data says
At $1.3B, Solventum's pp&e (net) ranks #34 of 132 in the Health Care sector. Declined from $1.5B to $1.3B over the past 2 years.
Based on SEC 10-K filings.
$1.3B in FY2025.
Declined from $1.5B to $1.3B over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#34 of 132 in Health CareTop 26% of 132This company $1.3B Sector average $1.4B
▼
-7.6% below sector average
Key checks
Key Insights
- In FY2025, pp&e (net) decreased 18.2% year-over-year.
- Ranks #34 out of 132 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 30.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | -18.2% |
| FY2024 | $1.6B | +11.3% |
| FY2023 | $1.5B | - |
| FY2022 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026